Innovators:                                                                                               

To visit each biotechnology innovator, you can click on the logo or name.
UC Davis investigators to receive NIH New Innovator funding

Elva Diaz, an assistant professor of pharmacology from the University of California Davis, researches to reprogram brain tumor stem cells. She will receive $1.5 million over five years if she develops novel therapies for childhood brain cancer. Diaz wants to replicate stem cell qualities, which allows her to characterize the molecular processes that support abnormal tissue growth and identity compounds that target those processes. (Citation 6)


Stem cell innovators find a way to cut out cancer

Shinya Yamanaka, from Kyoto University in Japan established that the stem cell breakthrough may have been thrilling, but is not ready to be used in a human being. He and James Thomson from the University of Wisconsin reported that they had used four genes to transform ordinary skin cells called fibroblasts into iPS cells. They are hoping to find a way for new medical treatments that can make use of the body’s on regenerative powers. (Citation 7)


Advanced Cell Technology, Inc.  is a biotechnology company that specializes in the improvement of cellular therapies for the treatment of rare and common diseases that impact millions of people worldwide. The company relates stem cell-based technologies and other proprietary methods in the area of regenerative medicine to bring patient-specific therapies from the lab to the bedside. (Citation 18)

Plasticell Secures $690,000 Including First Institutional Investment

Plasticell Company works with biotechnology and develops its innovative stem cell and drug screening products. So far it has developed and holds private academic property rights for two complementary systems in the fields of stem cell research and regenerative medicine.  The Company's Combinatorial Cell Culture™ product, known as CombiCult™, is a sophisticated method of directing the development of stem cells towards defined tissue types. (Citation 9)


Treating stroke with stem cells

 A team from the University of Texas Medical School in Houston recently made a medical history by treating a patient with stroke with his own stem cells, in the nation's first process. The patient, who is 61 years old, is now recovering fine without paralysis. This shows that the team’s technique holds promise of becoming a useful therapeutic tool for treating victims with stroke. (Citation 10)


A senior scientist named Wei-Qiang Gao from Genentech Incorporation is now examining normal prostate epithelial stem cells and prostate cancer stem cells. We used the renal capsule tissue recombination approach to verify the regeneration capability of the putative prostate epithelial stem cells. We also presented xenograft and/or orthotopic implantation experiments to resolve the tumorigenicity of putative prostate cancer stem cells. (Citation 17)
 
Make a Free Website with Yola.